Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 0378-0094

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 0378-0094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa And Levodopa Extended-release Tablets, Usp 25 mg/100 mg Bottle Label (Image 01)

Label for Carbidopa and Levodopa Extended-Release Tablets, USP, 25 mg/100 mg, manufactured by Mylan Pharmaceuticals Inc. The label shows the NDC 0378-0088-01 and indicates a package containing 100 tablets. The image includes dosage form, strength, manufacturer details, and storage instructions. An image of an oval tablet imprinted with '88' is also visible.*

FDA Label Image

Carbidopa And Levodopa Extended-release Tablets, Usp 50 mg/200 mg Bottle Label (Image 02)

Label of Carbidopa and Levodopa Extended-Release Tablets, USP, showing strengths of 50 mg carbidopa and 200 mg levodopa per tablet. The label specifies an extended-release oral tablet form. The product is manufactured by Mylan Pharmaceuticals Inc. and comes in a bottle of 100 tablets. Additional storage and dispensing instructions are provided, including storage at 25°C (77°F) and keeping medication out of reach of children.*

FDA Label Image

Carbidopa Structural Formula (Image 03)

Chemical structure of carbidopa monohydrate, showing its molecular configuration with hydroxyl groups, amine group, and carboxyl functional group, along with one molecule of water (H2O).*

FDA Label Image

Levodopa Structural Formula (Image 04)

Chemical structure of carbidopa, one of the active ingredients in Carbidopa and Levodopa extended-release tablets by Mylan Pharmaceuticals Inc. The diagram shows the molecular structure with hydroxyl, amino, and carboxyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.